Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

QIAstat-Dx® Respiratory Panel Plus

K-Number: K233100 · 2024-05-10

ApplicantQIAGEN GmbH
Decision Date2024-05-10
Product CodeQOF
Advisory CommitteeMI
DecisionSubstantially Equivalent

Device Summary

QIAstat-Dx® Respiratory Panel Plus is a medical device manufactured by QIAGEN GmbH. It received FDA 510(k) clearance on 2024-05-10 under approval number K233100. The device is classified under product code QOF. It was reviewed by the MI advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the QIAstat-Dx® Respiratory Panel Plus?

QIAstat-Dx® Respiratory Panel Plus is a medical device that received FDA 510(k) clearance on 2024-05-10. It is manufactured by QIAGEN GmbH. The 510(k) number is K233100.

When was QIAstat-Dx® Respiratory Panel Plus approved by the FDA?

QIAstat-Dx® Respiratory Panel Plus received FDA 510(k) clearance on 2024-05-10, under approval number K233100.

What company makes QIAstat-Dx® Respiratory Panel Plus?

QIAstat-Dx® Respiratory Panel Plus is manufactured by QIAGEN GmbH.

What is the FDA product code for QIAstat-Dx® Respiratory Panel Plus?

The FDA product code for QIAstat-Dx® Respiratory Panel Plus is QOF.

Other Devices by QIAGEN GmbH

View all 17 devices →

Related Devices (Code: QOF)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.